Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: A retrospective review of 1114 patients

Leukemia and Lymphoma

Volumn 46, Issue 12, 2005, Pages 1715-1720

  Darabi, Kamram ^a   Sieber, M ^b   Chaitowitz, M ^c   Braitman, L E ^d   Tester, W ^e   Diehl, V ^f  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Kreiskrankenhaus Gummersbach   (Germany)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN CANCER CENTER   (United States)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Hodgkin lymphoma; Infradiaphragmatic; Prognosis; Subdiaphragmatic; Supradiaphragmatic

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADVANCED CANCER; AGE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAPHRAGM; EARLY CANCER; ECHOGRAPHY; GENDER; GERMANY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTOMA; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; TREATMENT FAILURE;

ADULT; DIAPHRAGM; FEMALE; GERMANY; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 32144454687     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500144847     Document Type: Review

References (30)

1. Barton, M and O'Brien, P.(1999) Hodgkin's disease presenting below the diaphragm. In Hodgkin's disease. (pp. 727-737). Philadelphia PA: Lippincott Williams and Wilkins.
2. Leibenhaut, M and Hoppe, R and Varghese, A and Rosenberg, S. (1987) Subdiaphragmatic Hodgkin' disease: Laparotomy and treatment results in 49 patients Journal of Clinical Oncology, 5, pp. 1050-1055.
3. Mauch, P and Greenberg, H and Lewin, A and Cassady, J and Weichselbaum, R and Hellman, S. (1983) Prognostic factors in patients with subdiaphragmatic Hodgkin's disease Hematology & Oncology, 1, pp. 205-214.
4. Mauch, P and Tarbell, N and Weinstein, H and Silver, B and Gottman, T and Osteen, R and (1988) Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation Journal of Clinical Oncology, 6, pp. 1576-1583.
5. Peters, V. (1950) A study of survival in Hodgkin's disease treated radiologically American Journal of Roentgenology, 63, pp. 299-311.
6. Krikorian, J and Portlock, C and Rosenberg, S and Kaplan, H. (1979) Hodgkin's disease, stages I and II occurring below the diaphragm Cancer, 43, pp. 1866-1871.
7. Barrett, A and Gregor, A and McElwain, T and Peckham, M. (1981) Infradiaphragmatic presentation of Hodgkin's disease Clinical Radiology, 32, pp. 221-224.
8. Barton, M and Boyages, J and Crennan, E and Davis, S and Fischer, R and Hook, C. (1996) Radiotherapy for early infradiaphragmatic Hodgkin's disease: The Australasian experience Radiotherapy & Oncology, 39, pp. 1-7.
9. Cionini, L and Magrini, S and Mungai, V and Biti, G and Ponticelli, P. (1982) Stage I and II Hodgkin's disease presenting in infradiaphragmatic nodes Tumori, 68, pp. 519-525.
10. Dorreen, M and Wrigley, P and Laidlow, J. (1984) The management of stage II supradiaphragmatic Hodgkin' disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years Cancer, 54, pp. 2882 - 2888.
11. Enrici, R and Osti, M and Anselmo, A and Banelli, E and Cartoni, C and Sbarbati, S and (1996) Hodgkin's disease stage I and II with exclusive subdiaphragmatic presentation. The experience of the Department of Radiation Oncology and Hematology, University 'La Sapienza' of Rome Tumori, 82, pp. 48 - 52.
12. Henry-Amar, M and Aeppli, D and Abderson, J and Ashley, S and Bonicho, F and Cox, R and (1990) Workshop statistical report. In Treatment strategy in Hodgkin's disease: Collque INSERM. (pp. 217). London: Paris/France/ John Libbey Eurotext Ltd.
13. Krikorian, J and Portlock, C and Mauch, P. (1986) Hodgkin's disease presenting below the diaphragm: A review Journal of Clinical Oncology, 4, pp. 1551 - 1562.
14. Mai, D and Peschel, R and Portlock, C and Knowlton, A and Farber, L. (1991) Stage I and II sub diaphragmatic Hodgkin's disease Cancer, 68, pp. 1476 - 1481.
15. Mason, M and Law, M and Ashley, S and Nichols, J and Brada, M and Peckham, M and Horwich, A. (1992) Infradiaphragmatic Hodgkin's disease European Journal of Cancer, 28A, pp. 1851 - 1852.
16. Roos, D and O'Brien, P and Wright, J and Wilson, K. (1994) Treatment of subdiaphragmatic Hodgkin's disease: Is radiotherapy alone appropriate only for inguino-femoral presentations? International Journal of Radiation Oncology, Biology & Physics, 28, pp. 683-691.
17. Rappaport, H and Berard, C and Butler, J and Dorfman, R and Lukes, R and Thomas, L. (1971) Report of the committee on histopathological criteria contributing to staging of Hodgkin's disease Cancer Research, 31, pp. 1864 - 1865.
18. Kälkner K.M. Enblad G. and Gustavsson, A and Starkhammer, H and Branehog, I and Lenner, P and Glimelius, B. (1997) Infradiaphragmatic Hodgkin's disease: The Swedish National Care Programme experience. The Swedish Lymphoma Study Group European Journal of Haematology, 59, pp. 31 - 37.
19. Duehmke, E and Franklin, J and Pfreundschuh, M and Sehlen, S and Willich, N and Ruehl, U and (2001) Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone Journal of Clinical Oncology, 19, pp. 2905 - 2914.
20. Sieber, M and Tesch, H and Pfistner, B and Rueffer, U and Lathan, B and Brosteanu, O and (2002) Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the GHSG Trial HD5 Journal of Clinical Oncology, 20, pp. 476 - 484.
21. Kaplan, E and Meier, P. (1958) Non-parametric estimation from incomplete observations American Statistics Association Journal, 53, pp. 457 - 480.
22. Enblad, G and Glimelius, B and Sundstrom, C. (1991) Treatment outcome in Hodgkin's disease in patients above the age of 60: A population-based study Annals of Oncology, 2, pp. 297 - 302.
23. Epstein, E. (1939) Sex as a factor in the prognosis of Hodgkin's disease American Journal of Cancer, 35, pp. 230.
24. Gross, R and Zach, J and Schulten, H. (1966) Die Lymphogranulomatose. Diagnostisch-prognostische Hinweise anhand von 700 Fällen Dtsch Med Wschr, 91, pp. 521. (in German)
25. Heilmeyer, L and Mössner, G and Hunstein, W. (1957) Die Lymphogranulomatose Dtsch Med Wschr, 82, pp. 1046. (in German)
26. Musshoff, K and Busch, M and Kaminski, H. (1964) Lymphogranulomatose mit Knochenbefall. Symptomatologie mit besonderer Berücksichtigung des Röntgenbildes, Therapie und Prognose. Ein Bericht über 66 Fälle (Freiburger Krankengut 1948 - 1961) Fortschr Geb Röntgenstr, 101, pp. 117. (in German)
27. Somers, R and Tubiana, M and Henry-Amar, M. (1989) EORTC (European Organisation for Research and Treatment of Cancer) Lymphoma Cooperative Group studies in clinical stage I-II Hodgkin's disease 1963-1987 Recent Results in Cancer Research, 117, pp. 175 - 181.
28. Ferrant, A and Hamoir, V and Binon, J and Michaux, J and Sokal, G. (1985) Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease Cancer, 55, pp. 317 - 322.
29. Longo, D and Duffey, P and DeVita, V, Jr and Devita, V, Jr and Wiernik, P and Hubbard, S and (1991) Treatment of advanced-stage Hodgkin's disease: Alternating noncrossresistant MOPP/CABS is not superior to MOPP Journal of Clinical Oncology, 9, pp. 1409 - 1420.
30. Longo, D and Russo, A and Duffey, P. (1991) Treatment of advanced-stage massive Hodgkin's disease: The case of combined modality treatment Journal of Clinical Oncology, 9, pp. 227 - 235.